Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 09:02:27 26/10/26 pm AEDT			5-day change	1st Jan Change
2,448.15 ^INR	+1.80%		-1.67%	-0.92%

03/08	GSK India first-quarter profit rises on steady vaccine demand	RE
03/08	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	414,731	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	7.22%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	414,731	414,731
Change	-	-18.99%	58.51%	48.08%	-20.64%	7.22%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	35.6x	30.9x
PBR	10.6x	12.9x	18.5x	25x	17.1x	15.7x	13.2x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	2.9x	2x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	9.74x	8.78x
EV / Revenue	0x	0x	0x	0x	0x	9.74x	8.78x
EV / EBITDA	0x	0x	0x	0x	0x	28x	24.3x
EV / EBIT	0x	0x	0x	0x	0x	28.2x	24.2x
EV / FCF	0x	0x	0x	0x	0x	34.5x	31.5x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.89%	3.18%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.2%	1.2%
EPS ²	100	36.05	34.83	54.76	61.15	68.78	79.18
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	42.9%	37.3%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,568	47,241
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,836	17,070
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,698	17,112
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,654	13,418
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,448.15	2,448.15
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	16/5/22	17/5/23	17/5/24	13/5/25	13/5/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	34.97x	-	-	1.23%	4.29B
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.33x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	30.04x	7.04x	18.70x	2.03%	400.79B
Weighted average by Cap.	35.23x	8.29x	20.40x	1.8%